124 related articles for article (PubMed ID: 30396922)
1. Cystathione β-Synthase Is Increased in Thyroid Malignancies.
Turbat-Herrera EA; Kilpatrick MJ; Chen J; Meram AT; Cotelingam J; Ghali G; Kevil CG; Coppola D; Shackelford RE
Anticancer Res; 2018 Nov; 38(11):6085-6090. PubMed ID: 30396922
[TBL] [Abstract][Full Text] [Related]
2. Increased Nicotinamide Phosphoribosyltransferase and Cystathionine-β-Synthase in Renal Oncocytomas, Renal Urothelial Carcinoma, and Renal Clear Cell Carcinoma.
Shackelford RE; Abdulsattar J; Wei EX; Cotelingam J; Coppola D; Herrera GA
Anticancer Res; 2017 Jul; 37(7):3423-3427. PubMed ID: 28668830
[TBL] [Abstract][Full Text] [Related]
3. Nicotinamide phosphoribosyltransferase and SIRT3 expression are increased in well-differentiated thyroid carcinomas.
Shackelford R; Hirsh S; Henry K; Abdel-Mageed A; Kandil E; Coppola D
Anticancer Res; 2013 Aug; 33(8):3047-52. PubMed ID: 23898059
[TBL] [Abstract][Full Text] [Related]
4. Expression of inducible nitric oxide synthase in thyroid neoplasms: immunohistochemical and molecular analysis.
Choe W; Kim S; Hwang TS; Lee SS
Pathol Int; 2003 Jul; 53(7):434-9. PubMed ID: 12828608
[TBL] [Abstract][Full Text] [Related]
5. NITRIC OXIDE SYNTHASE ACTIVITY AND ITS CONCENTRATION IN THE TISSUES OF HUMAN THYROID CARCINOMAS.
Kalinichenko OV; Myshunina TM; Tron’ko MD
Fiziol Zh (1994); 2016; 62(3):9-19. PubMed ID: 29569867
[TBL] [Abstract][Full Text] [Related]
6. The natural protein kinase C alpha mutant is present in human thyroid neoplasms.
Prévostel C; Alvaro V; de Boisvilliers F; Martin A; Jaffiol C; Joubert D
Oncogene; 1995 Aug; 11(4):669-74. PubMed ID: 7651730
[TBL] [Abstract][Full Text] [Related]
7. E-cadherin/α-catenin deregulated co-expression in thyroid carcinoma based on tissue microarray digital image analysis.
Tsiambas E; Ragos V; Georgakopoulos G; Rigopoulos DN; Fotiades PP; Chatziioannidis A; Stamatelopoulos A; Vilaras G; Karameris A
J BUON; 2016; 21(2):450-5. PubMed ID: 27273957
[TBL] [Abstract][Full Text] [Related]
8. Dipeptidyl aminopeptidase IV in the cytologic diagnosis of thyroid carcinoma.
González-Cámpora R; Galera-Ruiz D; Armas-Padrón JR; Otal-Salaverri C; Galera-Davidson H
Diagn Cytopathol; 1998 Jul; 19(1):4-8. PubMed ID: 9664176
[TBL] [Abstract][Full Text] [Related]
9. CITED1 protein expression suggests Papillary Thyroid Carcinoma in high throughput tissue microarray-based study.
Prasad ML; Pellegata NS; Kloos RT; Barbacioru C; Huang Y; de la Chapelle A
Thyroid; 2004 Mar; 14(3):169-75. PubMed ID: 15072698
[TBL] [Abstract][Full Text] [Related]
10. [Cytokeratin expression of benign and malignant epithelial thyroid gland tumors. An immunohistologic study of 154 neoplasms using 8 different monoclonal cytokeratin antibodies].
Schröder S; Wodzynski A; Padberg B
Pathologe; 1996 Nov; 17(6):425-32. PubMed ID: 9082363
[TBL] [Abstract][Full Text] [Related]
11. Stromal fibroblasts adjacent to invasive thyroid tumors: expression of gelatinase A but not stromelysin 3 mRNA.
Zedenius J; Ståhle-Bäckdahl M; Enberg U; Grimelius L; Larsson C; Wallin G; Bäckdahl M
World J Surg; 1996 Jan; 20(1):101-6. PubMed ID: 8588399
[TBL] [Abstract][Full Text] [Related]
12. The efficacy of the thyroid peroxidase marker for distinguishing follicular thyroid carcinoma from follicular adenoma.
Savin S; Cvejic D; Isic T; Paunovic I; Tatic S; Havelka M
Exp Oncol; 2006 Mar; 28(1):70-4. PubMed ID: 16614712
[TBL] [Abstract][Full Text] [Related]
13. Expression profile of hydrogen sulfide and its synthases correlates with tumor stage and grade in urothelial cell carcinoma of bladder.
Gai JW; Qin W; Liu M; Wang HF; Zhang M; Li M; Zhou WH; Ma QT; Liu GM; Song WH; Jin J; Ma HS
Urol Oncol; 2016 Apr; 34(4):166.e15-20. PubMed ID: 26847849
[TBL] [Abstract][Full Text] [Related]
14. Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors.
Erickson LA; Jin L; Wollan PC; Thompson GB; van Heerden J; Lloyd RV
Mod Pathol; 1998 Feb; 11(2):169-74. PubMed ID: 9504687
[TBL] [Abstract][Full Text] [Related]
15. CD10 expression is useful in the diagnosis of follicular carcinoma and follicular variant of papillary thyroid carcinoma.
Tomoda C; Kushima R; Takeuti E; Mukaisho K; Hattori T; Kitano H
Thyroid; 2003 Mar; 13(3):291-5. PubMed ID: 12729479
[TBL] [Abstract][Full Text] [Related]
16. Neutrophil gelatinase-associated lipocalin (NGAL) immunohistochemical expression in follicular cell-derived thyroid tumors: a novel diagnostic tool?
Barresi V; Leni A; Tuccari G; Barresi G
Histol Histopathol; 2012 Mar; 27(3):329-36. PubMed ID: 22237710
[TBL] [Abstract][Full Text] [Related]
17. CD73 expression in normal, hyperplastic, and neoplastic thyroid: a systematic evaluation revealing CD73 overexpression as a feature of papillary carcinomas.
Monteiro I; Missiaglia E; Sciarra A; Santos JV; Bouilly J; Romero P; Sempoux C; de Leval L
Virchows Arch; 2021 Jul; 479(1):209-214. PubMed ID: 34019179
[TBL] [Abstract][Full Text] [Related]
18. Telomerase activity in benign and malignant thyroid tumors.
Haugen BR; Nawaz S; Markham N; Hashizumi T; Shroyer AL; Werness B; Shroyer KR
Thyroid; 1997 Jun; 7(3):337-42. PubMed ID: 9226200
[TBL] [Abstract][Full Text] [Related]
19. TROP-2 expression in papillary thyroid carcinoma: Potential Diagnostic Utility.
Simms A; Jacob RP; Cohen C; Siddiqui MT
Diagn Cytopathol; 2016 Jan; 44(1):26-31. PubMed ID: 26481593
[TBL] [Abstract][Full Text] [Related]
20. Expression of galectin-3 in fine-needle aspirates as a diagnostic marker differentiating benign from malignant thyroid neoplasms.
Inohara H; Honjo Y; Yoshii T; Akahani S; Yoshida J; Hattori K; Okamoto S; Sawada T; Raz A; Kubo T
Cancer; 1999 Jun; 85(11):2475-84. PubMed ID: 10357421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
